<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940722-0-00035</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  July 22, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4700 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Part 5</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Delegations of Authority and Organization  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Final rule. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is amending the regulations for delegations of authority relating to disclosure of official records in order to delegate authority to certain officials within the agency for disclosure to foreign governments. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  July 22, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Ellen R. Rawlings, Division of Management Systems and Policy (HFA&hyph;340), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4976. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  In the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  of November 19, 1993 (58 FR 61598), FDA published a final rule amending the regulations in &sect;20.89 (21 CFR 20.89), effective December 20, 1993, to provide that the Commissioner of Food and Drugs (the Commissioner) may designate any other FDA officer or employee to act on the Commissioner's behalf to authorize the nonpublic disclosure, under certain specified conditions, of confidential commercial information submitted to FDA or incorporated into agency-prepared records. This amendment permits such disclosure to foreign government officials who perform counterpart functions to FDA as part of cooperative law enforcement or regulatory efforts. The amendment also permits the disclosure of trade secret information to visiting foreign scientists under certain limited conditions. Section 5.23  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> Disclosure of official records <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  (21 CFR 5.23) is being revised to add &sect;20.89(c) to the sections already referenced in &sect;5.23(a), and to list those officials authorized to make such disclosures.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Further redelegation of the authority delegated is not authorized. Authority delegated to a position by title may be exercised by a person officially designated to serve in such position in an acting capacity or on a temporary basis. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects in 21 CFR Part 5 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Authority delegations (Government agencies), Imports, Organization and functions (Government agencies). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 5 is amended as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 5_DELEGATIONS OF AUTHORITY AND ORGANIZATION <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 5 continues to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority: <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  5 U.S.C. 504, 552, App. 2; 7 U.S.C. 138a, 2271; 15 U.S.C. 638, 1261&hyph;1282, 3701&hyph;3711a; secs. 2&hyph;12 of the Fair Packaging and Labeling Act (15 U.S.C. 1451&hyph;1461); 21 U.S.C. 41&hyph;50, 61&hyph;63, 141&hyph;149, 467f, 679(b), 801&hyph;886, 1031&hyph;1309; secs. 201&hyph;903 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321&hyph;394); 35 U.S.C. 156; secs. 301, 302, 303, 307, 310, 311, 351, 352, 361, 362, 1701&hyph;1706, 2101, 2125, 2127, 2128 of the Public Health Service Act (42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 264, 265, 300u&hyph;300u&hyph;5, 300aa&hyph;1, 300aa&hyph;25, 300aa&hyph;27, 300aa&hyph;28); 42 U.S.C. 1395y, 3246b, 4332, 4831(a), 10007&hyph;10008; E.O. 11490, 11921, and 12591; secs. 312, 313, 314 of the National Childhood Vaccine Injury Act of 1986, Pub. L. 99&hyph;660 (42 U.S.C. 300aa&hyph;1 note). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 5.23 is amended by revising the introductory text of paragraph (a) and by adding new paragraphs (a)(10)(i) through (a)(10)(vii) to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;5.23  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Disclosure of official records. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) The following officials are authorized to make determinations to disclose official records and information under part 20 of this chapter, except that only the officials listed in paragraph (a)(1) of this section may disclose official records and information under &sect;&sect;20.82 and 20.85 of this chapter, and only officials listed in paragraph (a)(10) of this section may disclose information under &sect;20.89(c) of this chapter. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (10)(i) The Associate Commissioner for Regulatory Affairs, Deputy Associate Commissioner for Regulatory Affairs, and Director, Office of Enforcement, FDA. <!-- PJG 0012 frnewline --> (ii) The Director, Deputy Director, and Associate Director for Policy Coordination and Public Affairs, Center for Biologics Evaluation and Research (CBER), and Director, Division of Congressional and Public Affairs, CBER. <!-- PJG 0012 frnewline --> (iii) The Director, Deputy Directors, and Associate Director for Science and Medical Affairs, Center for Drug Evaluation and Research (CDER). <!-- PJG 0012 frnewline --> (iv) The Director and Deputy Director for Regulations and Policy, Center for Devices and Radiological Health (CDRH). <!-- PJG 0012 frnewline --> (v) The Director, Center for Food Safety and Applied Nutrition (CFSAN), and Deputy Director for Systems and Support, CFSAN. <!-- PJG 0012 frnewline --> (vi) The Director and Deputy Director, Center for Veterinary Medicine (CVM). <!-- PJG 0012 frnewline --> (vii) The Director, Deputy Director, and Associate Director for Scientific Coordination, National Center for Toxicological Research (NCTR). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: July 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Michael R. Taylor, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Commissioner for Policy. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;17808 Filed 7&hyph;21&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            